Pfizer - 50 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits. The latest closing stock price for Pfizer as of December 02, 2022 is 50.91.
  • The all-time high Pfizer stock closing price was 59.33 on December 16, 2021.
  • The Pfizer 52-week high stock price is 61.71, which is 21.2% above the current share price.
  • The Pfizer 52-week low stock price is 41.45, which is 18.6% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 50.22.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 48.8650 54.8779 54.9166 41.3945 50.9100 -11.00%
2021 40.2197 34.3067 59.3340 31.5519 57.2028 66.74%
2020 31.9594 33.2149 39.6657 24.4250 34.3067 3.18%
2019 33.2993 35.3930 36.9668 28.7760 33.2488 -6.92%
2018 31.5661 28.7913 37.8316 26.8164 35.7203 24.82%
2017 26.4628 25.0907 29.3918 23.6841 28.6175 15.88%
2016 24.5338 23.3987 27.8501 21.1275 24.6953 4.46%
2015 24.3142 22.2002 26.0555 22.0798 23.6403 7.10%
2014 21.1298 20.8449 22.7387 19.4596 22.0727 5.30%
2013 19.5474 17.1573 22.0356 17.1175 20.9612 26.22%
2012 15.1069 14.0025 17.0845 13.4903 16.6072 20.41%
2011 12.2089 10.8147 13.9133 10.5135 13.7922 28.77%
2010 10.0565 11.1115 11.7396 8.4679 10.7107 0.31%
2009 9.0620 10.1746 11.0645 6.6361 10.6771 8.26%
2008 10.3933 11.9558 12.5664 8.0472 9.8627 -16.85%
2007 12.8830 13.1085 14.1015 11.6375 11.8619 -8.15%
2006 12.5878 11.4296 14.0687 10.9734 12.9141 15.22%
2005 12.0922 12.3346 13.6727 9.9012 11.2085 -10.62%
2004 15.2003 16.2404 17.7480 11.3273 12.5398 -22.31%
2003 14.4469 14.1360 16.3743 12.8675 16.1399 17.76%
2002 15.4999 17.6290 18.6231 11.5294 13.7056 -22.16%
2001 18.3246 20.1758 20.1758 15.6389 17.6069 -12.49%
2000 18.0943 13.8207 21.3423 13.0404 20.1189 43.06%
1999 16.6346 17.6997 21.5493 13.6828 14.0635 -21.50%
1998 14.5843 10.7649 18.0723 10.5160 17.9147 68.94%
1997 7.9629 5.7502 11.0664 5.7502 10.6042 81.93%
1996 5.1035 4.2994 6.3555 4.1958 5.8288 33.96%
1995 3.3059 2.5680 4.5756 2.5214 4.3512 66.70%
1994 2.1751 2.2309 2.6565 1.7725 2.6102 15.31%
1993 2.0795 2.3126 2.4192 1.7370 2.2637 -2.28%
1992 2.3723 2.6315 2.6863 2.0939 2.3164 -11.97%
1991 1.8414 1.2273 2.6863 1.1432 2.6315 112.75%
1990 1.0317 1.0487 1.2484 0.8354 1.2369 20.50%
1989 0.9140 0.8233 1.1041 0.7792 1.0265 24.14%
1988 0.7530 0.6672 0.8393 0.6672 0.8269 29.22%
1987 0.8938 0.8436 1.0409 0.5713 0.6399 -22.90%
1986 0.8199 0.6803 0.9899 0.6395 0.8300 20.48%
1985 0.6291 0.5493 0.7586 0.5187 0.6889 19.83%
1984 0.4855 0.4916 0.5749 0.4082 0.5749 18.19%
1983 0.5244 0.4609 0.6089 0.4609 0.4864 3.80%
1982 0.4111 0.3572 0.5426 0.3419 0.4686 29.34%
1981 0.3348 0.3623 0.3725 0.2772 0.3623 0.00%
1980 0.2826 0.2551 0.3623 0.2220 0.3623 35.29%
1979 0.2269 0.2253 0.2772 0.1990 0.2678 18.86%
1978 0.2161 0.1862 0.2611 0.1735 0.2253 21.00%
1977 0.1818 0.1956 0.1956 0.1599 0.1862 -6.43%
1976 0.1921 0.1931 0.2126 0.1735 0.1990 4.90%
1975 0.2033 0.2185 0.2483 0.1633 0.1897 -14.55%
1974 0.2256 0.2942 0.3002 0.1471 0.2220 -24.54%
1973 0.2985 0.2968 0.3564 0.2645 0.2942 0.86%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $285.774B $81.288B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $467.679B 18.00
Eli Lilly (LLY) United States $356.089B 44.94
AbbVie (ABBV) United States $289.429B 12.00
Novo Nordisk (NVO) Denmark $287.171B 37.66
Merck (MRK) United States $278.995B 14.37
Novartis AG (NVS) Switzerland $199.112B 15.00